Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 2,332 | 3,084 | 428 | 1,911 | -370 |
| Operating Income | -2,332 | -3,084 | -428 | -1,911 | 370 |
| Other Income | 14 | 17 | 36 | 10 | -2,250 |
| Pre-tax Income | -2,318 | -3,067 | -392 | -1,901 | -1,880 |
| Net Income Continuous | -2,318 | -3,067 | -392 | -1,901 | -1,880 |
| Net Income | $-2,318 | $-3,067 | $-392 | $-1,901 | $-1,880 |
| EPS Basic Total Ops | -0.23 | -0.28 | -0.04 | -0.20 | -0.21 |
| EPS Basic Continuous Ops | -0.22 | -0.29 | -0.04 | -0.20 | -0.22 |
| EPS Diluted Total Ops | -0.23 | -0.28 | -0.04 | -0.20 | -0.21 |
| EPS Diluted Continuous Ops | -0.22 | -0.29 | -0.04 | -0.20 | -0.22 |
| EBITDA(a) | $-2,332 | $-3,084 | $-428 | $-1,911 | $370 |